Oryzon Genomics: Final PORTICO data reaffirms potential in BPD according to a note of the analist of Edison Research
We received from Robert Seguin , Managing Partner, of WESTMOUNT CAPITAL , and we are pleased to publish the following note of the analist of Edison Research on the results of Oryzon Genomics on the final analysis from the Phase IIb PORTICO trial. "Oryzon has presented the results…